Essential Medicines Strategic Stockpile Act of 2021
- Last Action
- 4/29/2021
Actions
- 2021-04-29Referred to the Subcommittee on Health.
- 2021-04-28Referred to the House Committee on Energy and Commerce.
- 2021-04-28Introduced in House
- 2021-04-28Introduced in House
CRS Summary
As of 2021-04-28 (00)
Essential Medicines Strategic Stockpile Act of 2021
This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
Cosponsors (1)
- Lisa Blunt Rochester (D-DE)
Subjects
- Business records
- Congressional oversight
- Emergency medical services and trauma care
- Government information and archives
- Government studies and investigations
- Health care coverage and access
- Health programs administration and funding
- Health technology, devices, supplies
- Prescription drugs
- Public contracts and procurement
- Public-private cooperation
- Strategic materials and reserves
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.